fluoroquinolone warning
There was another FDA warning recently, this time regarding
systemic fluoroquinolones (ciprofloxacin, levofloxacin, etc), leading to a
boxed warning, the FDA’s strongest warning (see http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm500665.htm
for the summary, and http://www.fda.gov/Drugs/DrugSafety/ucm511530.htm
for the full report).
Details:
-- fluoroquinolones are associated with disabling and
potentially permanent adverse effects on tendons (tendinitis, tendon rupture),
muscles (muscle weakness or pain), joints (joint pain or swelling), peripheral
nerves (peripheral neuropathy), and the central nervous system (anxiety,
depression, hallucinations, suicidal thoughts, psychosis, confusion). Other
adverse effects include worsening of myasthenia gravis, skin rash, sunburn
(photosensitivity/phototoxicity), irregular heartbeat (including prolonged QT
interval), severe diarrhea (they are the leading cause of Clostridium difficile-associated
diarrhea). Multiple problems can occur in the same patient. The peripheral
neuropathy may be irreversible.
-- Therefore, fluoroquinolones should only be used in
patients where no other treatment options are available for acute bacterial
sinusitis, acute bacterial exacerbation of chronic bronchitis, and
uncomplicated urinary tract infections. Also for serious bacterial infections
where the benefits outweigh the risks.
-- The prior warnings for tendinitis, tendon rupture, and
worsening of myasthenia gravis has been extended by the above problems.
-- Side effects may occur within hours to weeks after
starting the fluoroquinolone and continue an average of 14 months to as long as
nine years after stopping the medicines. (Though, as noted, some may be irreversible)
-- the majority (74%) of reported cases were in patients 30
to 59 year-olds, some with severe resulting disabilities. Most of the adverse
reactions involve the musculoskeletal system, peripheral nervous system, and
central nervous system. Long-term pain was most commonly reported symptoms, 97%
of all cases reporting pain associated with musculoskeletal adverse effects
-- and, one should stop treatment at the first sign of an
adverse reaction
commentary:
-- although many of the musculoskeletal and central nervous
system effects have been known for many years, the above update includes many
other conditions. And some of the newly included conditions (eg peripheral
neuropathy) can last forever.
-- My sense locally is that fluoroquinolones are still
being used quite frequently for uncomplicated urinary tract infections and
other relatively minor infections. Hopefully the above warning will further
discourage their potentially unnecessary usages.
-- I’m also very concerned about antibiotic resistance
overall, as many of you know. Please see http://gmodestmedblogs.blogspot.com/search/label/antibiotic%20resistance for many blogs highlighting in rather scary detail the increasing antibiotic
resistance in general, both in the US and worldwide. And I am also concerned
about the effect of broad-spectrum antibiotics in particular and fundamental
changes in the gut microbiome which can lead to many known, and probably many
more unknown, health complications (see many blogs in http://gmodestmedblogs.blogspot.com/search/label/microbiome )
Comments
Post a Comment
if you would like to receive the near-daily emails regularly, please email me at gmodest@uphams.org